Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 187 (1), E21-E31

Common Harms From Amoxicillin: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials for Any Indication

Affiliations
Review

Common Harms From Amoxicillin: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials for Any Indication

Malcolm Gillies et al. CMAJ.

Abstract

Background: When prescribing antibiotics for common indications, clinicians need information about both harms and benefits, information that is currently available only from observational studies. We quantified the common harms of the most frequently prescribed antibiotic, amoxicillin, from randomized placebo-controlled trials.

Methods: For this systematic review, we searched MEDLINE, Embase and the Cochrane Central Register of Controlled Trials, without language restriction, for any randomized, participant-blinded, placebo-controlled trials of amoxicillin or amoxicillin-clavulanic acid for any indication, in any setting. Our main outcome was any reported adverse event.

Results: Of 730 studies identified, we included 45 trials: 27 involving amoxicillin, 17 involving amoxicillin-clavulanic acid and 1 involving both. The indications for antibiotic therapy were variable. The risk of bias was low, although only 25 trials provided data suitable for assessment of harms, which suggested under-reporting. Diarrhea was attributed to amoxicillin only in the form of amoxicillin-clavulanic acid (Peto odds ratio [OR] 3.30, 95% confidence interval [CI] 2.23-4.87). The OR for candidiasis (3 trials) was significantly higher (OR 7.77, 95% CI 2.23-27.11). Rashes, nausea, itching, vomiting and abnormal results on liver function tests were not significantly increased. The results were not altered by sensitivity analyses, nor did funnel plots suggest publication bias. The number of courses of antibiotics needed to harm was 10 (95% CI 6-17) for diarrhea with amoxicillin-clavulanic acid and 27 (95% CI 24-42) for candidiasis with amoxicillin (with or without clavulanic acid).

Interpretation: Diarrhea was caused by use of amoxicillin-clavulanic acid, and candidiasis was caused by both amoxicillin and amoxicillin-clavulanic acid. Harms were poorly reported in most trials, and their true incidence may have been higher than reported. Nevertheless, these rates of common harms associated with amoxicillin therapy may inform decisions by helping clinicians to balance harms against benefits.

Figures

Figure 1:
Figure 1:
Selection of studies for inclusion in a meta-analysis of common harms in randomized placebo-controlled trials of amoxicillin or amoxicillin–clavulanic acid.
Figure 2:
Figure 2:
Number of trials, subdivided according to whether or not harms were reported, by year of publication.
Figure 3A:
Figure 3A:
Meta-analyses of reported harms with amoxicillin and amoxicillin–clavulanic acid: diarrhea and candidiasis. CI = confidence interval, OR = odds ratio.
Figure 3B:
Figure 3B:
Meta-analyses of reported harms with amoxicillin and amoxicillin–clavulanic acid: nausea, vomiting and rash. CI = confidence interval, OR = odds ratio.

Comment in

Similar articles

See all similar articles

Cited by 30 PubMed Central articles

See all "Cited by" articles
Feedback